You are now leaving the website.

The linked sites are not under the control of Amgen, and Amgen is not responsible for the content available on the linked sites. Such links do not imply Amgen's endorsement of material on any other site, and Amgen disclaims all liability with regard to your access to such linked websites. Amgen provides links to other Internet sites as a convenience to users, and access to such linked sites is at your own risk.


My Time My Voice: Episode 4 – Who Pays for Cancer Drugs?

My Time My Voice: Episode 4 – Who Pays for Cancer Drugs?

Who pays for cancer drugs in Canada? How do they decide which ones to pay for? The answers to these questions aren’t simple, but they are important for people living with cancer to know — because patients can help in making those decisions.

In this episode of My Time, My Voice, pharma policy consultant Judy Glennie helps us make sense of the process, and provides some tips on how to get your voice heard.

“A single voice pulled together with hundreds of other single voices has more power than the individual voice.”
— Judy Glennie

Play Episode

in this episode

Guest: Judy Glennie
Dr. Glennie is the President of J.L. Glennie Consulting Inc., which provides strategic advisory services to non-profit, government and industry clients. She has more than 25 years of experience in the national and international pharmaceutical policy world and is a clinical pharmacist by background.
Host: Michelle Jobin
Michelle is a TV personality, producer and writer with more than a decade of experience in broadcast and online media covering lifestyle, weather and news content.

Listen on

spotify podcast googlepodcast

Do you want to link to our other external sites and leave

You are now leaving the Amgen Canada website. Please note that the information you are about to view may not comply with Canadian regulatory requirements. Marketing authorizations and availability of products may differ between Canada and other countries.